{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:09:36Z","timestamp":1789978176874,"version":"4.0.1"},"reference-count":10,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"unspecified","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2020,7,13]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Neuromyelitis optica is a devastating, relapsing, inflammatory, autoimmune disorder characterised in large part by attacks of optic neuritis and transverse myelitis causing blindness and plegia in many patients. Eighty-three per cent of patients with transverse myelitic attacks and 67% of patients with optic neuritis attacks have no or a partial recovery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Results from The European Group for Blood and Marrow Transplantation Autoimmune Diseases Working Party imply failure of autologous haematopoietic stem cell bone marrow transplantation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results and conclusion<\/jats:title>\n                  <jats:p>We present a case that despite eventual relapse, made a remarkable functional recovery after bone marrow transplantation which may justify bone marrow transplantation in severe cases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2020-000073","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T16:10:18Z","timestamp":1603728618000},"page":"e000073","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Plegia to walking: AHSCBMT in severe NMOSD relapse"],"prefix":"10.1136","volume":"2","author":[{"given":"Nicola","family":"Carlisle","sequence":"first","affiliation":[{"name":"Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Hari","sequence":"additional","affiliation":[{"name":"Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3713-8890","authenticated-orcid":false,"given":"Staley","family":"Brod","sequence":"additional","affiliation":[{"name":"Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"2025072811510570000_2.2.e000073.1","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"key":"2025072811510570000_2.2.e000073.2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.msard.2018.12.011","article-title":"Long-Term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis\/preventive treatment, MRI lesion length and presence of symptomatic brain lesions","volume":"28","author":"Mealy","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"2025072811510570000_2.2.e000073.3","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws109"},{"key":"2025072811510570000_2.2.e000073.4","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-14"},{"key":"2025072811510570000_2.2.e000073.5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4\u2013Positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N Engl J Med"},{"key":"2025072811510570000_2.2.e000073.6","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1056\/NEJMoa1901747","article-title":"Trial of Satralizumab in neuromyelitis optica spectrum disorder","volume":"381","author":"Yamamura","year":"2019","journal-title":"N Engl J Med"},{"key":"2025072811510570000_2.2.e000073.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31817-3"},{"key":"2025072811510570000_2.2.e000073.8","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514541978"},{"key":"2025072811510570000_2.2.e000073.9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/bmt.2009.305","article-title":"Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis","volume":"45","author":"Tappenden","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"2025072811510570000_2.2.e000073.10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00410","article-title":"Regenerating immunotolerance in multiple sclerosis with autologous hematopoietic stem cell transplant","volume":"9","author":"Massey","year":"2018","journal-title":"Front Immunol"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2020-000073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:51:12Z","timestamp":1753728672000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2020-000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,10,26]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bmjno-2020-000073"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2020-000073","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}